Titan Pharmaceuticals logo
Titan Pharmaceuticals TTNP
$ 3.83 4.99%

Квартальный отчет 2024-Q2
добавлен 15.08.2024

report update icon

Titan Pharmaceuticals Мультипликаторы 2011-2024 | TTNP

Мультипликаторы по годам Titan Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.9 -0.1 -1.2 - -0.4 -1.6 -2.0 16.4 -6.3 -18.8 6.1 -8.1 -4.7

P/S

28.4 0.9 6.6 2.1 1.7 2.4 133.1 5.6 42.4 12.4 5.7 17.3 17.4

EPS

-7.4 -15.2 - -2.0 -0.7 -1.6 -0.7 0.2 -0.6 -0.0 0.1 -0.2 -0.3

EV (Enterprise Value)

-82.1 тыс. 275 тыс. 6.93 млн 9.45 млн 9.06 млн 12.3 млн 29.1 млн 75.5 млн 69.2 млн 42 млн 60.2 млн 153 млн 95.8 млн

EBITDA per Share

-9.53 -14.9 -0.92 -2.16 -21.7 -19.8 -120 41 -57.5 -32.9 -9.45 -124 -175

EV/EBITDA

-0.7 -0.8 -0.3 -1.2 -2.0 14.8 -9.8 -9.5 -60.7 -14.0 -7.4

PEG

-0.0 -0.0 0.01 - -0.05 -0.02 0.01 0.11 0.03 0.15 0.04 -0.7 0.02

P/B

0.8 0.4 2.0 2.9 4.3 2.1 33.4 6.4 10.1 5.3 10.3 -5.3 -3.5

P/CF

-0.7 -0.1 -1.3 -0.6 -0.4 -1.6 -2.2 13.7 -9.3 -7.7 -5.9 181.8 -4.8

ROE %

-83.85 -748.79 -170.81 - -1148.50 -132.09 -1669.43 38.93 -161.36 -27.91 168.59 65.63 75.72

ROA %

-68.87 -251.50 -109.78 - -172.84 -64.02 -160.66 27.51 -84.89 -11.52 52.71 -61.14 -148.80

ROCE %

-109.56 -750.92 -182.06 -190.24 -284.43 -77.65 -326.55 31.45 -80.14 -24.49 -11.76 -243.74 -206.24

Current Ratio

5.6 1.5 2.8 1.7 2.3 3.9 1.9 3.7 2.5 2.9 1.6 1.1 1.9

DSO

81.3 48.5 119.1 - 100.4 113.4 110.3 86.9 920.3 397.2 167.8 238.3 333.8

DIO

- - 569.5 253.6 282.8 856.2 - - - - - - -

DPO

- - 1878.2 969.0 397.0 1035.3 - - - - - - -

Операционный цикл

81.3 48.5 688.6 253.6 383.2 969.6 - - - - - - -

Финансовый цикл

81.3 48.5 -1189.6 -715.3 -13.8 -65.7 - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Titan Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-2.29 -1.24 - -0.02 -2.11 -2.23 - -0.18 -0.18 -0.24 - - -0.17 -0.28 - -0.05 -0.05 -0.07 -0.08 -0.18 -0.38 -0.34 -0.29 -0.64 -0.25 -0.74 -1.04 -0.2 -0.16 -0.14 -0.11 -0.12 0.58 -0.09 -0.11 -0.09 -0.11 -0.24 -0.02 0.04 -0.01 -0.02 - -0.01 0.06 0.08 - -0.12 -0.03 -0.09 -0.05 -0.01 -0.12 -0.08

EBITDA per Share

- -1.24 - - - -2.2 - -0.17 -0.17 -0.23 - -0.18 -0.22 -0.28 - -0.3 -0.47 -0.69 - -238 -0.35 -0.32 - -442 -0.02 -0.11 - -0.18 -0.16 -0.16 - -0.11 0.6 -0.09 - -0.08 -0.05 -0.08 - -0.03 - -0.01 - - - - - -0.04 -0.03 -0.06 - - - -

ROE %

-78.13 127.66 686.09 611.78 541.62 344.79 -149.98 -175.53 -126.76 -102.53 -71.22 -210.85 -324.94 -437.14 -429.13 -704.15 -760.12 -991.38 -1148.50 -924.78 -759.11 -409.17 -132.09 -507.86 -966.96 -1356.92 -1669.43 -1260.00 -790.83 -297.72 38.93 23.75 17.76 -105.30 -161.36 -134.03 -99.87 -77.01 -27.91 -26.04 -54.24 43.46 168.59 173.43 227.96 147.50 65.63 78.86 48.21 75.57 75.72 4.00 34.81 22.47

ROA %

-70.83 -218.03 -275.96 -317.99 -356.65 -190.92 -96.25 -116.12 -93.95 -78.96 -53.58 -114.56 -155.68 -198.47 -187.42 -228.81 -197.26 -194.45 -172.84 -156.31 -141.38 -92.97 -64.02 -80.26 -112.81 -145.40 -160.66 -132.03 -99.00 3.65 27.51 22.71 23.14 -57.92 -84.89 -69.89 -52.86 -39.73 -11.52 -10.39 -20.04 11.49 52.71 52.72 26.66 -7.77 -61.14 -88.38 -63.97 -125.44 -148.80 -7.87 -68.41 -44.16

ROCE %

-120.07 85.43 672.15 597.70 548.59 351.92 -149.75 -175.21 -126.21 -109.70 -78.41 -112.27 -120.68 -139.91 -135.59 -406.56 -643.67 -938.54 -910.68 -939.25 -696.86 -365.53 -73.17 -548.08 -994.42 -1407.58 -1298.48 -1318.31 -863.23 -349.41 57.59 31.81 25.86 -81.06 -64.51 -73.08 -55.87 -46.63 -25.80 -28.03 -21.68 -20.36 -4.32 7.17 20.88 33.46 34.28 44.03 42.28 55.68 48.51 9.75 20.92 17.84

Current Ratio

12.2 11.9 5.6 5.4 0.4 0.9 1.5 2.3 3.1 4.2 2.8 4.5 4.2 3.6 1.8 1.8 1.8 1.8 1.2 1.2 1.2 1.2 1.9 1.9 1.9 1.9 1.1 1.1 1.1 1.1 3.4 3.4 3.4 3.4 2.1 2.1 2.1 2.1 1.7 1.7 1.7 1.7 1.4 1.4 1.4 1.4 0.5 0.5 0.5 0.5 0.3 0.3 0.3 0.3

DSO

- - - 399.2 9.3 20.5 - 72.0 97.0 78.4 - 63.6 51.4 85.8 - 79.2 64.6 53.6 53.6 95.7 180.5 131.8 128.2 96.1 59.4 77.3 102.3 148.3 77.0 4165.6 9351.8 12589.0 21.8 - - - 505.8 409.7 397.0 397.4 397.4 440.0 482.6 200.0 200.0 83.5 130.1 345.2 311.7 300.6 240.2 335.4 488.4 -

DIO

- - - - - - - - - - - 59.1 177.9 226.5 - - - - - 484.4 370.2 339.2 - 647.0 1645.1 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - 189.2 618.8 838.3 - - - - - 680.0 519.7 439.3 - 782.3 1989.2 - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - 399.2 9.3 20.5 - 72.0 97.0 78.4 - 122.8 229.3 312.2 - 79.2 64.6 53.6 53.6 580.1 550.7 471.0 128.2 743.0 1704.5 77.3 102.3 148.3 77.0 4165.6 9351.8 12589.0 21.8 - - - 505.8 409.7 397.0 397.4 397.4 440.0 482.6 200.0 200.0 83.5 130.1 345.2 311.7 300.6 240.2 335.4 488.4 -

Финансовый цикл

- - - 399.2 9.3 20.5 - 72.0 97.0 78.4 - -66.4 -389.5 -526.0 - 79.2 64.6 53.6 53.6 -99.9 31.0 31.7 128.2 -39.3 -284.7 77.3 102.3 148.3 77.0 4165.6 9351.8 12589.0 21.8 - - - 505.8 409.7 397.0 397.4 397.4 440.0 482.6 200.0 200.0 83.5 130.1 345.2 311.7 300.6 240.2 335.4 488.4 -

Все данные представлены в валюте USD